🇺🇸 FDA
Pipeline program

Recombinant human hyaluronidase PH20 (rHuPH20)

HALO-117-104

Phase 1 small_molecule completed

Quick answer

Recombinant human hyaluronidase PH20 (rHuPH20) for Healthy is a Phase 1 program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
HALOZYME THERAPEUTICS, INC.
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials